Atrial Fibrillation and Risk of Dementia: Epidemiology, Mechanisms, and Effect of Anticoagulation
- PMID: 30766470
- PMCID: PMC6365433
- DOI: 10.3389/fnins.2019.00018
Atrial Fibrillation and Risk of Dementia: Epidemiology, Mechanisms, and Effect of Anticoagulation
Abstract
Atrial fibrillation (AF) is one of the cardiovascular risk factors for dementia. Several longitudinal studies have reported an association between AF and dementia independently of stroke history. Although the mechanisms underlying this association are not fully understood, proposed mechanisms include cerebral hypoperfusion, inflammation, genetic factors, cerebral microbleeds, and recurrent silent cerebral ischemia. Oral anticoagulation can be used to minimize risk of cognitive decline and dementia, given that brain insults can be caused by chronic microemboli or microbleeds. However, controversy on the effects of warfarin and direct oral anticoagulants on this risk exists. This article will address these aspects, with data on the studies already published and a critical view on this subject.
Keywords: Alzheimer's disease; anticoagulation therapy; atrial fibrillation; cognition; dementia.
References
-
- Alonso A., Knopman D. S., Gottesman R. F., Soliman E. Z., Shah A. J., O'Neal W. T., et al. (2017). Correlates of dementia and mild cognitive impairment in patients with atrial fibrillation: the atherosclerosis risk in communities neurocognitive study (ARIC-NCS). J. Am. Heart. Assoc. 6:e006014. 10.1161/JAHA.117.006014 - DOI - PMC - PubMed
-
- Chen L. Y., Norby F. L., Gottesman R. F., Mosley T. H., Soliman E. Z., Agarwal S. K., et al. (2018). Association of atrial fibrillation with cognitive decline and dementia over 20 years: the ARIC-NCS (Atherosclerosis Risk in Communities Neurocognitive Study). J. Am. Heart. Assoc. 7: e007301. 10.1161/JAHA.117.007301 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
